申请人:Scarborough M. Robert
公开号:US20050107357A1
公开(公告)日:2005-05-19
2,4-Dioxo-3-quinazolinylaryl sulfonylurea compounds are provided that are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
提供了2,4-二氧-3-喹唑啉基芳基磺酰脲化合物,可用于抑制ADP-血小板聚集,特别是在治疗血栓和血栓相关疾病或疾病方面。